C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2004
11/04/2004	WO2004094388A2 Indazole derivatives as jnk inhibitors
11/04/2004	WO2004094386A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
11/04/2004	WO2004094382A1 Muscarinic agonists
11/04/2004	WO2004094381A1 Cyclic quaternary amino derivatives as modulators of chemokine receptors
11/04/2004	WO2004094380A1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists
11/04/2004	WO2004093873A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
11/04/2004	WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	WO2004093817A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/04/2004	WO2004093798A2 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
11/04/2004	WO2004093789A2 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/04/2004	WO2004074812A3 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/04/2004	WO2004069792A8 Quinoline-derived amide modulators of vanilloid vr1 receptor
11/04/2004	WO2004066950A3 Quinoline derivatives as nk-2 and nk-3 receptor antagonists
11/04/2004	WO2004056769B1 Synthesis of amines and intermediates for the synthesis thereof
11/04/2004	WO2004004657A3 Hiv integrase inhibitors
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	US20040220402 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
11/04/2004	US20040220247 N-[4-(4,5-Dihydro-1H-imidazol-2-yl-amino)-benzyl]-4-methoxy-benzamide and derivatives; prostaglandin inhibitors; urinary tract disease, disease related pain, neuropathic pain, respiratory asthma, allergy
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220232 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone which is reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine; useful as p38 kinase and COX-2 inhibitors
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004	US20040220229 insulin resistance; central nervous system disorders; vision defects; anticholesterol agents;antilipemic agents; antiischemic agents
11/04/2004	US20040220223 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
11/04/2004	US20040220222 Malonamide derivatives
11/04/2004	US20040220207 Chemokine receptor binding heterocyclic compounds
11/04/2004	US20040220196 antitumor agents; 4-amino-5-fluoro-3-(6-( 4-methylpiperazin-1-yl)1H-benzimidazol-2-yl)-quinolin-2-one
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220191 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
11/04/2004	US20040220188 Alkylidene pyrazolidinedione derivatives
11/04/2004	US20040220185 antiinflammatory agents; antiarthritic agents; anticancer agents
11/04/2004	US20040220177 Anticancer agents
11/04/2004	US20040220174 for example, 1-(4-methoxyphenyl)-7-oxo-6-[5-(2-oxo-1-piperidinyl)2-pyridinyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; use as anticoagulant agent for treatment of thromboembolic disorders
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/04/2004	DE10315772A1 Chemische Verbindung und Verfahren für den intramolekularen Energietransfer zur Abspaltung von labilen funktionellen Gruppen aus chemischen Verbindungen Chemical compound and method for the intramolecular energy transfer to the cleavage of labile functional groups from chemical compounds
11/04/2004	CA2526880A1 Cyclic quaternary amino derivatives as modulators of chemokine receptors
11/04/2004	CA2523200A1 Nk-2 antagonist basic linear compounds and formulations containing them
11/04/2004	CA2522805A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004	CA2522687A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors
11/04/2004	CA2522682A1 Indazole derivatives as jnk inhibitors
11/04/2004	CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	CA2522562A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
11/04/2004	CA2518839A1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists
11/04/2004	CA2518324A1 Muscarinic agonists
11/04/2004	CA2518180A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
11/03/2004	EP1473294A2 Substituted 1,3-oxathiolanes with antiviral properties
11/03/2004	EP1472245A2 Heteroaryl compounds useful as inhibitors of gsk-3
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004	EP1472223A1 Gamma secretase inhibitors
11/03/2004	EP1471915A2 2,4-pyrimidinediamine compounds and their uses
11/03/2004	EP1471914A1 Pharmaceutical composition for regeneration of cirrhotic liver
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1471786A1 Microbiocidal n-phenyl-n- 4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
11/03/2004	EP1456176A4 Improved compounds for generating chemiluminescence with a peroxidase
11/03/2004	EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004	EP1232153B1 Imidazole derivatives and their use as raf kinase inhibitors
11/03/2004	EP1206452B1 Novel method for preparing benzoperhydroisoindole compounds
11/03/2004	EP1189883B1 Substituted pyrrolidines as cell adhesion inhibitors
11/03/2004	EP0942906B1 Compounds useful for inhibition of farnesyl protein transferase
11/03/2004	CN1543463A Stereoselective methods for the preparation of nucleosides
11/03/2004	CN1543455A 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
11/03/2004	CN1543346A Novel compounds
11/03/2004	CN1543344A Aryl(or hetero aryl) aza cyclopentadienyl carbinol ramifications for treating urinary incontinence
11/03/2004	CN1542001A Small molecule inhibitors of rotamase enzyme activity
11/03/2004	CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
11/03/2004	CN1173951C Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
11/03/2004	CN1173947C 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
11/03/2004	CN1173946C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/02/2004	US6812243 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation
11/02/2004	US6812237 (arylaminoaceamido)acetonitrile derivatives
11/02/2004	CA2315614C Pyrazoles
11/02/2004	CA2301787C New derivatives of benzo[3,4]cyclobuta[1,2-c]pyrrole, the procedure for preparing them and the pharmaceutical compounds that contain them
11/02/2004	CA2153903C Process for the preparation of 10-desacetoxybaccatin iii
11/02/2004	CA2129040C Styryl derivatives and processes for their preparation
10/2004
10/28/2004	WO2004092196A2 Tie-2 modulators and methods of use
10/28/2004	WO2004092164A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
10/28/2004	WO2004092140A1 Biaryl substituted pyrazoles as sodium channel blockers
10/28/2004	WO2004092134A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004	WO2004091605A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
10/28/2004	WO2004091518A2 Cxcr4 chemokine receptor binding compounds
10/28/2004	WO2004091485A2 Aminoquinoline compounds
10/28/2004	WO2004078732B1 N-aryl heteroaromatic products, compositions containing same and use thereof
10/28/2004	WO2004078103A3 G-lactam derivatives as prostaglandin agonists
10/28/2004	WO2004058721A3 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
10/28/2004	WO2004037789A3 Methylene urea derivatives as raf-kinase inhibitors
10/28/2004	US20040215019 Substituted isoindoles and the e use thereof
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214880 Antitumor agents, anticarcinogenic agents; inhibitors of histone deacetylase; a methyleneaminooxymethyl)-thiophene-2-carboxylic acid (2-amino-phenyl)-amide derivatives; chemical synthesis
10/28/2004	US20040214874 Inhibition of protein-tyrosine kinase cmet to block cancer cell proliferation, oral bioavailibility; 2-(2,6-dichlorophenyl)-4-phenyl-5-(pyrimidin-4yl)-1H-imidazoles
10/28/2004	US20040214868 Treatment or prevention of type 2 diabetes; chemical synthesis; 2-[ benzoyl]aminopyridine-5-carboxylate derivatives
10/28/2004	US20040214862 A N'-hydroxy-terephthalamide derivatives; histone deacetylase enzyme inhibitors; ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS
10/28/2004	US20040214857 Substituted benzimidazoles and imidazo-[4,5]-pyridines
10/28/2004	US20040214845 Barbiturates as integrin antagonists and their use for treating inflammatory diseases
10/28/2004	US20040214844 N4-acylcytosine nucleosides for treatment of viral infections
10/28/2004	US20040214832 Piperazine derivative renin inhibitors
10/28/2004	US20040214818 Alzheimer's disease; Parkinson's disease; Huntington's disease; cognition activators; learning enhancement; central nervous system disorders

1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 523